Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-Thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders - Contacts and Locations

Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-Thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders

This study is currently recruiting participants.

Study NCT00010335. Last updated on September 2, 2008. Information provided by Office of Rare Diseases (ORD)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00010335

Locations


United States, Washington
	Fred Hutchinson Cancer Research Center	Recruiting
	Seattle, Washington, United States, 98109
	Contact: Ann Woolfrey 206-667-4453
	Contact: Carol A. Wallace, MD 206-987-4448 cwallace@u.washington.edu

Sponsors and Collaborators

Fred Hutchinson Cancer Research Center

Investigators


Study Chair:	Ann Woolfrey	Fred Hutchinson Cancer Research Center

Principal Investigator:	Carol A. Wallace, MD	Fred Hutchinson Cancer Research Center